The effect of oral magnesium supplementation on glycemic control and metabolic parameters in type 2 diabetes mellitus: a double-blind randomized controlled tria

This randomized controlled trial (RCT) assessed the effect of oral magnesium (Mg) supplementation on glycated hemoglobin (HbA1c) and metabolic biomarkers in adults with Type 2 Diabetes Mellitus (T2DM). This was a prospective, randomized, double-blind, placebo-controlled, parallel

Medical Literature · Updated 2026-08-02

← Back to articles

This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.